Currently out of the existing stock ratings of Jason Wittes, 87 are a BUY (82.86%), 18 are a HOLD (17.14%).

Jason Wittes

Work Performance Price Targets & Ratings Chart

Analyst Jason Wittes, carries an average stock price target met ratio of 62.47% that have a potential upside of 44.16% achieved within 293 days. Previously, Jason Wittes worked at ROTH MKM, AEGIS, LOOP CAPITAL, NORTHLAND CAPITAL MARKETS, BREAN.

Jason Wittes’s has documented 202 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 15-Jul-2025.

Wall Street Analyst Jason Wittes

Analyst best performing recommendations are on BWAY (BRAINSWAY LTD).
The best stock recommendation documented was for BWAY (BRAINSWAY LTD) at 8/10/2023. The price target of $1.38 was fulfilled within 1 day with a profit of $0.03 (2.22%) receiving and performance score of 22.22.

Average potential price target upside

ARAY Accuray ATEC Alphatec Holdings GMED Globus Medical STXS Stereotaxis SYK Stryker TFX Teleflex ZBH Zimmer Biomet Holdings VAR Varian Medical Systems BWAY Brainsway Ltd NUVA NuVasive NVCR Novocure Ltd MASI Masimo CLDX Celldex Therapeutics LMAT LeMaitre Vascular MDWD Mediwound Ltd PGNX Progenics Pharmaceuticals ENOV Enovis Corp OFIX Orthofix Medical IRMD Iradimed Co TLSI TriSalus Life Sciences INO Inovio Pharmaceuticals TGTX TG Therapeutics VRAY ViewRay MGRM MDXG MiMedx Group DERM Journey Medical Corp WMGI Wright Medical Group N.V

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$4

$2.92 (270.37%)

$7

10 months 8 days ago
(06-Nov-2025)

0/3 (0%)

$2.78 (227.87%)

Buy

$9

$7.92 (733.33%)

2 years 7 months 1 days ago
(13-Feb-2024)

0/3 (0%)

$6.25 (227.27%)

Buy

$10

$8.92 (825.93%)

$10

4 years 10 months 19 days ago
(26-Oct-2021)

0/5 (0%)

$5.7 (132.56%)

Hold

$4.25

$3.17 (293.52%)

$4

7 years 2 months 4 days ago
(10-Jul-2019)

3/3 (100%)

$0.59 (16.12%)

99

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?